[1] Astruc P. Augustin-Marie Morvan[J]. Prog Med, 1957:177-178.
[2] Neusom-Davis J, Buckley C, Clover L, et al. Autoimmune disorders of neuronal potassium channels[J]. Ann N Y Acad, 2003, 998(1):202-210.
[3] 王莉, 余琴, 余巨明,等. 电压门控性钾通道抗体病及其治疗[J]. 中国临床神经科学, 2011, 19(6):635-641.
[4] Sunwoo JS, Lee ST, Byun JI, et al. Clinical manifestations of patients with CASPR2 antibodies[J]. J Neuroimmunol, 2015, 281:17-22.
[5] van Sonderen A, Ariño H, Petit-Pedrol M,et al. The clinical spectrum of Caspr2 antibody-associated disease[J]. Neurology, 2016.
[6] 吴恒趋, 李建萍, 张瑛. 莫旺综合征:1例报道及文献复习[J]. 神经病学与神经康复学杂志, 2016,12(3):168-172.
[7] Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases[J]. Ann Neurol, 2012, 72(2):241-255.
[8] Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K+ channel antibodies[J]. Neurology, 2000, 54(3):771-772.
[9] Romana H. Neuroimmunology: an expanding frontier in autoimmunity[J]. Front Immunol, 2015, 6:206.
[10] Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data[J]. Vaccine, 2011, 29(3):599-612. |
